Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Z Wygoda"'
Autor:
J, Markowski, M, Oczko-Wojciechowska, T, Gierek, M, Jarzab, J, Paluch, M, Kowalska, Z, Wygoda, A, Pfeifer, T, Tyszkiewicz, B, Jarzab, I, Niedzielska, H, Borgiel-Marek
Publikováno v:
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 60
The assessment of gene expression profile in laryngeal cancer shall allow to implement molecular biology methods in diagnostics, as well as in prognosis of the course of disease. Thus, it may influence the choice of the most optimal decisions in rega
Autor:
B, Jarzab, J, Roskosz, M, Gawkowska-Suwińska, M, Turska, D, Handkiewicz-Junak, Z, Puch, Z, Wygoda, A, Zajusz
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 3(2)
The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (DTC) is already approved, however its application in (131)I therapy is still to be evaluated. We report results obtained in four patients with DTC met
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 54
Retinoids, a large group of compounds structurally related to vitamin A, are able to induce redifferentiation of thyroid cancer cells. The aim of the study is to present our early results of retinoids redifferentiation therapy of thyroid cancer patie
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 54
Intraoperative probes become increasingly important in the surgical management of cancer. Attempts with gamma probe guided surgery to improve the completeness of surgical excision of radioiodine avid tissues in thyroid cancer have been performed thro
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 54
The diagnostics with the use of recombinant human TSH for the follow-up of differentiated thyroid carcinoma (DTC) has been already approved. In more than 400 diagnostic scans, rhTSH proved to be effective in promoting 131I uptake in thyroid remnants
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 54
Medullary thyroid carcinoma (MTC) can be divided into two subgroups: sporadic or inherited. Hereditary form of MTC is often believed to be form with better prognosis than sporadic one. In this study the differences in MTC prognosis in Polish populati
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 54
Preliminary results of treatment of inherited medullary thyroid carcinoma, diagnosed primarily with genetic analysis of mutation of protooncogene RET are presented. Among 16 carriers of mutation identical with mutation diagnosed earlier in proband, t
Autor:
M, Gawkowska-Suwińska, M, Turska, J, Roskosz, Z, Puch, B, Jurecka-Tuleja, D, Handkiewicz-Junak, Z, Wygoda, B, Jarzab
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 54
This paper presents the preliminary results of a prospective randomized trial on early effectiveness of 30 mCi versus 60 mCi for ablation of thyroid remnants in patients with WDTC after total thyroidectomy. Since April 1998 to January 2000, 220 patie
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 54
Somatic mutations of the RET protooncogene are present in 23-68% cases of sporadic medullary thyroid carcinoma (MTC). The aim of the study was to introduce the RET somatic mutations analysis in tumor tissue as well as to evaluate their types and freq
Publikováno v:
Folia histochemica et cytobiologica. 39
The study was undertaken to evaluate the frequency of RET polymorphisms at codons 769 and 836 in young medullary thyroid carcinoma (MTC) patients in whom the presence of a known germline mutation has been excluded. 40 patients aged 10-29 were subject